Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$220.09 - $273.15 $167,048 - $207,320
759 Added 29.07%
3,370 $752,000
Q4 2023

Feb 14, 2024

BUY
$181.44 - $260.22 $184,705 - $264,903
1,018 Added 63.9%
2,611 $656,000
Q3 2023

Nov 15, 2023

BUY
$240.69 - $338.77 $226,007 - $318,105
939 Added 143.58%
1,593 $385,000
Q2 2023

Aug 23, 2023

BUY
$271.54 - $344.06 $177,587 - $225,015
654 New
654 $225,000
Q4 2022

Feb 14, 2023

BUY
$151.88 - $228.5 $85,812 - $129,102
565 Added 18.66%
3,593 $799,000
Q3 2022

Nov 14, 2022

BUY
$120.36 - $205.88 $364,450 - $623,404
3,028 New
3,028 $581,000
Q3 2021

Nov 12, 2021

SELL
$250.72 - $291.24 $213,864 - $248,427
-853 Reduced 51.67%
798 $212,000
Q2 2021

Aug 06, 2021

BUY
$235.0 - $310.7 $387,985 - $512,965
1,651 New
1,651 $457,000
Q1 2021

May 14, 2021

SELL
$175.6 - $291.43 $471,134 - $781,906
-2,683 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$174.98 - $272.83 $200,002 - $311,844
-1,143 Reduced 29.87%
2,683 $475,000
Q3 2020

Nov 13, 2020

SELL
$185.27 - $238.73 $367,019 - $472,924
-1,981 Reduced 34.11%
3,826 $740,000
Q3 2019

Nov 14, 2019

BUY
$131.82 - $183.4 $765,478 - $1.07 Million
5,807 New
5,807 $767,000
Q1 2019

May 15, 2019

SELL
$115.84 - $160.31 $298,983 - $413,760
-2,581 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$113.42 - $156.48 $644,339 - $888,962
-5,681 Reduced 68.76%
2,581 $322,000
Q1 2018

May 15, 2018

BUY
$84.6 - $126.1 $286,117 - $426,470
3,382 Added 69.3%
8,262 $956,000
Q4 2017

Feb 14, 2018

BUY
$91.55 - $115.85 $129,543 - $163,927
1,415 Added 40.84%
4,880 $459,000
Q3 2017

Nov 15, 2017

BUY
$79.65 - $90.3 $275,987 - $312,889
3,465
3,465 $313,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.01B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.